YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE007557
ID:	TCMBANKHE007557
植物拉丁名:	Herha Ajugae Ciliatae
功能与主治:	1. To clear lung-heat, eliminate phlegm and relieve cough. 2. to clear away heat and toxic material, and relieve carbuncle. 3. Clear away heat to cool the blood. 4. Lower blood pressure./Swelling pain in throat, lung heat cough, pulmonary welling abscess, red eyes with gall, dysentery, swollen welling abscess and clove sores, poisonous snake bite, knocks and falls.
药用植物名:	白毛夏枯草
药用部位:	whole herb
临床特征:	1. Antitussive and expectorant. 2. Its acid-alcoholic extract exerts an antiasthmatic effect on experimental animals with asthma.3. Its alcoholic extract inhibits the growth of Streptococcus and Straphylococcus aureus in vitro.
治疗类型:	清热解毒药
TCM_ID_id:	3926
SymMap_id:	17
TCMSP_id:	903

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000083	Decursin	decursin; C09258; SMR001397016; MLS002472905; CHEMBL1715398; [(7S)-8,8-dimethyl-2-oxo-6,7-dihydropyrano[5,6-g]chromen-7-yl] 3-methylbut-2-enoate; NCGC00247453-01; Decursinol angelate; (S)-7,8-Dihydro-8,8-dimethyl-2-oxo-2H,6H-benzo(1,2-b:5,4-b')dipyran-7-yl 3-methyl-2-butenoate; 5928-25-6; HMS2198C14; decursin ; 3-methylbut-2-enoic acid [(7S)-8,8-dimethyl-2-oxo-6,7-dihydropyrano[5,6-g]chromen-7-yl] ester; 3-methylbut-2-enoic acid [(7S)-2-keto-8,8-dimethyl-6,7-dihydropyrano[5,6-g]chromen-7-yl] ester; 2-Butenoic acid, 3-methyl-, 7,8-dihydro-8,8-dimethyl-2-oxo-2H,6H-benzo(1,2-b:5,4-b')dipyran-7-yl ester, (S)-	C19H20O5	328.36	CC(=CC(=O)OC1CC2=C(C=C3C(=C2)C=CC(=O)O3)OC1(C)C)C
TCMBANKIN002418	butenolide b	butenolide B	C14H18O3	234.29	CCC(C)CCC(C1C(COC1=O)CO)O
TCMBANKIN002485	[(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate	(E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester; [(4R,4aR,5S,7R,8S,8aR)-5-hydroxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate	C25H36O6	432.55
TCMBANKIN002713	[(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate	[(3S,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-3-hydroxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester	C27H38O8	490.59
TCMBANKIN003022	cynatratoside f,glaucoside h	cynatratoside f, glaucoside h
TCMBANKIN003203	butenolide a
TCMBANKIN003239	hinesol	hinesol	C15H26O	222.37	CC1CCC=C(C12CCC(C2)C(C)(C)O)C
TCMBANKIN005654	cynanchol				CC(=O)C1=C(C(=C(C=C1)O)C2=C(C3=C(C=C2)C(O3)(C)C(=O)C)O)O
TCMBANKIN006143	reptoside_qt		C17H26O10	390.38
TCMBANKIN009053	decumbesterone A	(2S,3R,5R,10R,13R,17S)-17-[(2R)-2,3-dihydroxy-5-(1-hydroxyethyl)-6-methylhept-6-en-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; AC1NSU9D; decumbesterone a	C29H46O7	506.7 g/mol	CC(C(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(=C)C)O
TCMBANKIN009508	[(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate	(E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; [(4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester	C27H38O7	474.59
TCMBANKIN010255	12-(α-methyl butyryl)-14-acetyl-2 e,8 e,10 e-atractylentriol	12-(α-methyl butyryl)-14-acetyl-2e,8 e,10 e-atractylentriol; 12(alpha-methyl butyryl)-14-acetyl-2e,8e,10e-atractylentriol
TCMBANKIN014404	decumbeside A		C24H28O11	492.47
TCMBANKIN018771	ajugamarinh1		C34H48O11	632.7 g/mol	CCC(C)C(=O)OC1CCC2(CO2)C3(C1C(C(CC3OC(=O)C)C)(C)CC(C4=CC(=O)OC4)OC(=O)C(=CC)C)COC(=O)C
TCMBANKIN018777	[(1S)-2-[(1S,2R,4S,4aR,5R,8R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-spiro[decalin-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (E)-2-methylbut-2-enoate	[(1S)-2-[(1S,2R,4S,4aR,5R,8R,8aR)-4-acetyloxy-4a-(acetyloxymethyl)-1,2-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-spiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (E)-2-methylbut-2-enoate; [(1S)-2-[(1S,2R,4S,4aR,5R,8R,8aR)-4-acetyloxy-4a-(acetyloxymethyl)-1,2-dimethyl-8-[(2S)-2-methylbutanoyl]oxyspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1S)-2-[(1S,2R,4S,4aR,5R,8R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-spiro[decalin-5,2'-oxirane]-1-yl]-1-(5-keto-2H-furan-3-yl)ethyl] ester; (E)-2-methylbut-2-enoic acid [(1S)-2-[(1S,2R,4S,4aR,5R,8R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-spiro[decalin-5,2'-oxirane]yl]-1-(5-oxo-2H-furan-3-yl)ethyl] ester	C34H48O11	632.74
TCMBANKIN018931	decumbeside C		C26H32O13	552.52
TCMBANKIN020150	[(1S)-2-[(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (2S)-2-methylbutanoate	[(1S)-2-[(1S,2R,4S,4aR,5R,8aR)-4-acetyloxy-4a-(acetyloxymethyl)-1,2-dimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (2S)-2-methylbutanoate; (2S)-2-methylbutanoic acid [(1S)-2-[(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-1-spiro[decalin-5,2'-oxirane]yl]-1-(5-oxo-2H-furan-3-yl)ethyl] ester; [(1S)-2-[(1S,2R,4S,4aR,5R,8aR)-4-acetyloxy-4a-(acetyloxymethyl)-1,2-dimethyl-spiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-oxirane]-1-yl]-1-(5-oxo-2H-furan-3-yl)ethyl] (2S)-2-methylbutanoate; (2S)-2-methylbutyric acid [(1S)-2-[(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-4a-(acetoxymethyl)-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-1-yl]-1-(5-keto-2H-furan-3-yl)ethyl] ester	C29H42O9	534.64
TCMBANKIN021494	Ajugalactone	42975-12-2; ajugalactone; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[1-(4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione; AC1NSUZW; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-6-keto-5-methyl-2,3-dihydropyran-2-yl]-1-hydroxy-ethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-quinone; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxy-ethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione; C08810; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione	C29H40O8	516.62	CCC1=C(C(=O)OC(C1)C(C)(C2CCC3(C2(C(=O)CC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O)C
TCMBANKIN026194	[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate	[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutanoic acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-1-spiro[decalin-4,2'-oxirane]yl] ester; [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutyric acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-8-[(2S)-2-acetoxy-2-(5-keto-2H-furan-3-yl)ethyl]-4a-(acetoxymethyl)-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] ester	C31H44O11	592.67
TCMBANKIN027312	8-acetylharpagide	8-acetylharpagide	C17H26O11	406.4 g/mol	CC(=O)OC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)C
TCMBANKIN027755	decumbeside D		C26H32O13	552.52
TCMBANKIN028148	[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] (E)-2-methylbut-2-enoate	(E)-2-methylbut-2-enoic acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-8-[(2S)-2-acetoxy-2-(5-keto-2H-furan-3-yl)ethyl]-4a-(acetoxymethyl)-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] ester; [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-1-spiro[decalin-4,2'-oxirane]yl] ester; [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (E)-2-methylbut-2-enoate	C31H42O11	590.66
TCMBANKIN029024	atractyenolide
TCMBANKIN030593	cynanversicoside
TCMBANKIN031481	jurubine	LMST01070002; Jurubine; 3beta-amino-26-O-[beta-D-glucopyranosyl]-25R-furostan-22alpha,26-diol	C33H57NO8	595.8 g/mol	CC1C2C(CC3C2(CCC4C3CCC5C4(CCC(C5)N)C)C)OC1(CCC(C)COC6C(C(C(C(O6)CO)O)O)O)O
TCMBANKIN031612	Harpagide 7-acetate_qt	8-O-acetylharpagide_qt	C17H26O11	406.38
TCMBANKIN032020	ajugamarin H2			632.82
TCMBANKIN032939	Cycasin	WLN: T6OTJ BO1NUNO&1 CQ DQ EQ F1Q GLUCO; methylazoxymethanol beta-D-glucoside; NSC15190; Methylazoxymethanol glucoside; Cycas revoluta glucoside; 14901-08-7; NSC-15190; Methylazoxymethanol.beta.-D-glucoside; .beta.-D-glucosyloxyazoxymethane; .beta.-D-Glucopyranoside, (methyl-ONN-azoxy)methyl; [(Methyl-ONN-azoxy)methyl]-.beta.-D-glucopyranoside; Methylazoxymethanol .beta.-D-glucoside; cycasin; CYCASIN; .beta.-D-Glucopyranoside, [(methyl-ONN-azoxy)methyl]-	C8H16N2O7	252.22	C[N+](=NCOC1C(C(C(C(O1)CO)O)O)O)[O-]
TCMBANKIN033205	14(α-methyl butyryl)-2 e,8 e,10 e-atractylentriol	14(α-methyl butyryl)-2e,8 e,10 e-atractylentriol; 14(alpha-methyl butyryl)-2e,8e,10e-atractylentriol
TCMBANKIN034537	decumbeside B		C24H28O11	492.47
TCMBANKIN034731	[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] ethanoate	MEGxp0_000602; acetic acid [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] ester; ACon1_000486; acetic acid [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] ester; [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] acetate; [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] acetate	C17H26O11	406.38	CC(=O)OC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)C
TCMBANKIN034750	12-(α-methyl butyryl)-14-acetyl-2 e,8z,10 e-atractylentriol	[(4E,6Z,12E)-1-acetyloxy-14-hydroxytetradeca-4,6,12-trien-8,10-diyn-3-yl] 2-methylbutanoate; 12-(α-methyl butyryl)-14-acetyl-2e,8z,10 e-atractylentriol; AC1NSY8M; 12(alpha-methyl butyryl)-14-acetyl-2e,8z,10e-atractylentriol
TCMBANKIN035681	14(α-methyl butyryl)-2 e,8z,10 e-atractylentriol	14(α-methyl butyryl)-2e,8z,10 e-atractylentriol; AC1NSY8S; [(4E,6Z,12E)-3,14-dihydroxytetradeca-4,6,12-trien-8,10-diynyl] 2-methylbutanoate; 14(alpha-methyl butyryl)-2e,8z,10e-atractylentriol			CCC(C)C(=O)OCCC(C=CC=CC#CC#CC=CCO)O
TCMBANKIN036817	atractylenolide I	(4aS,8aS)-3,8a-dimethyl-5-methylene-4a,6,7,8-tetrahydro-4H-benzo[f]benzofuran-2-one; Atractylenolide I; (+)-Atractylenolide; (4aS,8aS)-3,8a-dimethyl-5-methylidene-4a,6,7,8-tetrahydro-4H-benzo[f][1]benzoxol-2-one	C15H18O2	230.302	C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])(C([H])=C2C(=C(C([H])([H])[H])C(=O)O2)C3([H])[H])[C@]3([H])C(=C([H])[H])C1([H])[H]
TCMBANKIN037143	ecdysterone	2beta,3beta,14alpha,20beta,22,25-Hexahydroxy-7-cholesten-6-one; ZINC04165898; ST5412041; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; AIDS-013374; AIDS013374; CHEMBL1707235; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R)-1,2,5-trihydroxy-1,5-dimethylhexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; HMS2225F24; SMR001397251; beta-Ecdysone; (2Beta,3beta,5beta)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one; H5142_SIGMA; 20-Hydroxyecdysone; SCHEMBL19213295; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methyl-heptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; 20-OH ecdysone; Ecdysterone; Insect moulting hormone; 20E; 2,3,14-Trihydroxy-10,13-dimethyl-17-(1,2,5-trihydroxy-1,5-dimethyl-hexyl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-6-one; MLS002473159; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R)-1,2,5-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (22R)-2beta,3beta,14alpha,20,22,25-hexahydroxy-5beta-cholest-7-en-6-one; 5289-74-7; CHEBI:16587	C27H44O7	481	[C@@]1([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@](C([H])([H])[H])(O[H])[C@]([H])(O[H])C([H])([H])C([H])([H])C(O[H])(C([H])([H])[H] )C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]23O[H])C3=C([H])C4=O)[C@@]4([H])C([H])([H])[C@@]1([H])O[H]
TCMBANKIN037308	β-Eudesmol	2-Naphthaleneethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-; SCHEMBL12633040; beta-eudesmol; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-decalin-2-yl]propan-2-ol; 17790_FLUKA; 2-Naphthalenemethanol, decahydro-8-methylene-alpha,alpha,4a-trimethyl-, (2R-(2-alpha,4a-alpha,8a-beta)-; 2-[(2R,4aR,8aS)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; 3beta-(1-Hydroxy-1-methylethyl)-5-methylene-8abeta-methyldecahydronaphthalene; Beta- Eudesmol; (2R,4aR,8aS)-Decahydro-8-methylene-alpha,alpha,4a-trimethyl-2-naphthylmethanol; β- eudesmol; Eudesm-4(14)-en-11-ol (8CI); beta-Selinenol; rel-2-[(2R,4aR,8aS)-4a-methyl-8-methylenedecahydronaphthalen-2-yl]propan-2-ol; 2-naphthalenemethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-, (2R,4aR,8aS)-; C09664; InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12-13,16H,1,5-10H2,2-4H3/t12-,13+,15-/m1/s; beta-eudesmol ; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-2-decalinyl]propan-2-ol; AC1NSVC6; 2-[(2R,4aR)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; beta-Eudesmol; beta- eudesmol; 473-15-4; 4(15)-eudesmen-11-ol		222.37
TCMBANKIN037707	atratoside d		C40H60O13
TCMBANKIN037864	Ajugamarin F4			534.6 g/mol
TCMBANKIN038818	Ajugamarin B2			592.7 g/mol
TCMBANKIN039006	atratoside a		C42H64O13	776.9 g/mol	CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC(C6=O)(C)C7=C(OC=C7)C)C)C)OC)O
TCMBANKIN039130	ajugacumbin b		C25H36O6	432.5 g/mol	CC=C(C)C(=O)OCC12C(CCCC13CO3)C(C(CC2O)C)(C)CCC4=CC(=O)OC4
TCMBANKIN039292	atratoside c		C48H72O18
TCMBANKIN039355	Ajugasterone B	ajugasterone B		506.7 g/mol
TCMBANKIN039593	Reptoside	CHEMBL518538		390.38
TCMBANKIN040496	Ajugacumbin D			490.6 g/mol
TCMBANKIN040800	Ajugacumbin A	124961-66-6; [(4aR,5S,7R,8S,8aR)-5-acetyloxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate; AC1O5X9F		474.6 g/mol
TCMBANKIN040865	Ajugamarin A2			590.7 g/mol
TCMBANKIN040873	ajugasterone C	C08811; Ajugasterone C; (2S,3R,5R,9R,10R,11R,13R,14S,17S)-17-[(2R,3R)-2,3-dihydroxy-6-methyl-heptan-2-yl]-2,3,11,14-tetrahydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,11R,13R,14S,17S)-17-[(2R,3R)-2,3-dihydroxy-6-methylheptan-2-yl]-2,3,11,14-tetrahydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; 23044-80-6; (2S,3R,5R,9R,10R,11R,13R,14S,17S)-17-[(1R,2R)-1,2-dihydroxy-1,5-dimethyl-hexyl]-2,3,11,14-tetrahydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,11R,13R,14S,17S)-17-[(1R,2R)-1,2-dihydroxy-1,5-dimethylhexyl]-2,3,11,14-tetrahydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one	C33H52O7	561	[C@]12([H])[C@]([H])(OC(C([H])([H])[H])(C([H])([H])[H])O1)C([H])([H])[C@]3([H])[C@@](C([H])([H])[H])([C@@]([H])([C@]([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]4(C([H])([H])[H])OC(C([H] )([H])[H])(C([H])([H])[H])O[C@]4([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]56O[H])C6=C([H])C3=O)C2([H])[H]
TCMBANKIN042858	Luteolin	Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone	C15H10O6	286.236	c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H]
TCMBANKIN043294	neocynanversicoside		C29H40O11
TCMBANKIN044062	2α-(α-Methylbutyryl)-oxy-5α,7β,10β-triacetoxy-4(20),11-taxadiene
TCMBANKIN046923	Atratoside B
TCMBANKIN047677	atractylentriol		C14H16O3		C(CO)C(C=CC=CC#CC#CC=CCO)O
TCMBANKIN048180	Ajugacumbin F	ajugacumbin f		450.57
TCMBANKIN048669	Ajugacumbin E			606.7 g/mol
TCMBANKIN048951	ajugacumbin C	ajugacumbin c; Ajugacumbin C	C31H42O11	590.66	CC=C(C)C(=O)OCC12C(CC(C(C1C(CC(C23CO3)OC(=O)C)OC(=O)C)(C)CCC4=CC(=O)OC4)C)OC(=O)C
TCMBANKIN049083	Ajugamarin G1	ajugamarin g1		632.74
TCMBANKIN049327	Atracty lentrid		C14H16O3	232.275	C([H])([H])(O[H])\C([H])=C([H])\C#CC#C\C([H])=C([H])\C([H])=C([H])\[C@]([H])(O[H])C([H])([H])C([H])([H])O[H]
TCMBANKIN049586	Ajugamarin			548.62
TCMBANKIN050428	8β-Ethoxy atractylenolide III
TCMBANKIN050457	Ecdysterone-3-O-beta-D-glucopyranoside	AC1NSV0K; ecdysterone-3-o-beta-d-glucopyranoside; 2,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-(1,2,5-trihydroxy-5-methylhexyl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; ecdysterone-3-o-β-d-glucopyranoside		628.84	CC12CCC3C(=CC(=O)C4C3(CC(C(C4)OC5C(C(C(C(O5)CO)O)O)O)O)C)C1(CCC2C(C(CCC(C)(C)O)O)O)O
TCMBANKIN058272	esculetin	AIDS-014709; CCG-38509; Cichoriin aglycon; KBioSS_001646; KUC108669N; NSC-26428; ZINC00057908; SM2XD6V944; HMS1570L22; ILEDWLMCKZNDJK-UHFFFAOYSA-N; NSC26428; Esculetol; ZX-AN021876; BPBio1_000968; MolPort-000-709-311; 6,7-Dihydroxycoumarin, 8CI; FCH1117729; ST24044991; 6,7-dihydroxy-2-chromenone; Coumarin, 6,7-dihydroxy-; NCGC00094873-01; KBio1_001374; NCGC00016425-01; Prestwick1_000940; AS-11863; LS-55161; CHEBI:490095; 2H-1-BENZOPYRAN-2-ONE,6,7-DIHYDROXY; RTR-013104; KSC-11-243-1; 7H-1-Benzopyran-7-one, 2,6-dihydroxy-; Esculetol); W-2566; DTXSID3075383; KS-0000017Z; 2,6-Dihydroxy-7H-chromen-7-one; NCGC00016425-04; Cichoriin aglucon; Spectrum5_000512; CD-051; ZX-AFC000486; BG01504928; KSC148K7L; SR-01000721907-2; HMS1921M14; ACM305356; E0386; Aesculetin (cichorigenin; NSC 26428; Aesculetin; s4711; EBD2197580; NCGC00016425-05; NCGC00094873-02; AK591206; AN-44203; BRN 0152788; 6,7-dihydroxy-2H-chromen-2-one; Esculatin; KBio2_006782; AB00489955; GTPL5180; SCHEMBL24641; 6,7-Dihydroxycoumarin; ACMC-20luwt; SR-01000721907; Esculin aglycon; SPECTRUM1500899; MFCD00006874; Cichorigenin; BIB6051; UNII-SM2XD6V944; I14-1622; BDBM34571; ST5306833; CHEMBL244743; TR-013104; MLS000069479; CAS-305-01-1; 6,7-Dihydroxy-2-chromenone; SMR000059055; C09263; 6,7-dihydroxychromen-2-one; esculetin ; HMS3373K09; DivK1c_006430; 3.05E+13; E-3401; HMS2233G24; InChI=1/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11; SpecPlus_000334; Spectrum4_001886; MCULE-4460039316; Esculetin; AC1NQYFH; Prestwick2_000940; A820407; Prestwick3_000940; Oprea1_719746; 6,7-bis(oxidanyl)chromen-2-one; Asculetine; ST079379; KBioGR_002416; AIDS014709; AC-18400; AKOS030559695; 91753-33-2; CJ-00486; KBio3_001584; FT-0620854; SMP2_000093; 305-01-1; AB0010898; 5-18-03-00202 (Beilstein Handbook Reference); CE0046; KBio2_001646; BSPBio_000880; Spectrum2_000586; 6,7-Dihydroxy-2H-1-benzopyran-2-one; SC-45867; DB-014626; CC-22332; BSPBio_002364; CTK3G3670; SDCCGMLS-0066669.P001; ALBB-023362; SPBio_000432; AC1Q7980; 6,7-Dihydroxy-2-benzopyrone; Prestwick0_000940; AJ-09788; C-06350; NCGC00016425-03; AK114506; 6,7-Dihydroxycoumarin, 98%; ZINC57908; EINECS 206-161-5; cid_5281416; BRD-K58149231-001-06-9; 2H-1-Benzopyran-2-one, 6,7-dihydroxy-; bmse000986; 4CN-0872; 6,7-dihydroxy-1-benzopyran-2-one; BN0888; HMS2097L22; Bio-0588; SPBio_003049; C9H6O4; E-3400; KBio2_004214; Spectrum_001166; Esculetin, analytical standard; 2H-1-Benzopyran-2-one, 6,7-dihydroxy- (9CI); N1764; 6,7-DIHYDROXYCOUMARIN; Coumarin, 6,7-dihydroxy- Esculetin; J10146; Esculetin, European Pharmacopoeia (EP) Reference Standard; 246573_ALDRICH; ZB002263; Esculin aglucon; 6,7-dihydroxy-coumarin; KB-50565; NCI60_002119; ANW-43483; 6,7-Dihydroxy-2H-chromen-2-one; D0YZ5G; NCGC00016425-06; Jsp005751; AX8020100; AKOS000276955; NCGC00016425-02; CCRIS 7065; 6,7-Dihydroxy-2H-chromen-2-one #; Spectrum3_000752; 6, 7-dihydroxycoumarin; aesculetin; 6,7-dihydroxycoumarin; 6,7-dihydroxy coumarin; CCG-38509; Cichoriin aglycon; KBioSS_001646; KUC108669N; NSC-26428; SM2XD6V944; HMS1570L22; ILEDWLMCKZNDJK-UHFFFAOYSA-N; NSC26428; Esculetol; ZX-AN021876; BPBio1_000968; MolPort-000-709-311; 6,7-Dihydroxycoumarin, 8CI; FCH1117729; ST24044991; Coumarin, 6,7-dihydroxy-; NCGC00094873-01; KBio1_001374; NCGC00016425-01; Prestwick1_000940; AS-11863; LS-55161; CHEBI:490095; 2H-1-BENZOPYRAN-2-ONE,6,7-DIHYDROXY; RTR-013104; KSC-11-243-1; 7H-1-Benzopyran-7-one, 2,6-dihydroxy-; Esculetol); W-2566; DTXSID3075383; KS-0000017Z; 2,6-Dihydroxy-7H-chromen-7-one; NCGC00016425-04; Cichoriin aglucon; Spectrum5_000512; CD-051; ZX-AFC000486; BG01504928; KSC148K7L; SR-01000721907-2; HMS1921M14; ACM305356; E0386; Aesculetin (cichorigenin; NSC 26428; Aesculetin; s4711; EBD2197580; NCGC00016425-05; NCGC00094873-02; AK591206; AN-44203; BRN 0152788; Esculatin; KBio2_006782; AB00489955; GTPL5180; SCHEMBL24641; ACMC-20luwt; SR-01000721907; Esculin aglycon; SPECTRUM1500899; MFCD00006874; Cichorigenin; BIB6051; UNII-SM2XD6V944; I14-1622; BDBM34571; CHEMBL244743; TR-013104; MLS000069479; CAS-305-01-1; 6,7-Dihydroxy-2-chromenone; SMR000059055; C09263; 6,7-dihydroxychromen-2-one; HMS3373K09; DivK1c_006430; 3.05E+13; E-3401; HMS2233G24; InChI=1/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11; SpecPlus_000334; Spectrum4_001886; MCULE-4460039316; Esculetin; AC1NQYFH; Prestwick2_000940; A820407; Prestwick3_000940; Oprea1_719746; 6,7-bis(oxidanyl)chromen-2-one; Asculetine; ST079379; KBioGR_002416; AC-18400; AKOS030559695; 91753-33-2; CJ-00486; KBio3_001584; FT-0620854; SMP2_000093; 305-01-1; AB0010898; 5-18-03-00202 (Beilstein Handbook Reference); CE0046; KBio2_001646; BSPBio_000880; Spectrum2_000586; 6,7-Dihydroxy-2H-1-benzopyran-2-one; SC-45867; DB-014626; CC-22332; BSPBio_002364; CTK3G3670; SDCCGMLS-0066669.P001; ALBB-023362; SPBio_000432; AC1Q7980; 6,7-Dihydroxy-2-benzopyrone; Prestwick0_000940; AJ-09788; C-06350; NCGC00016425-03; AK114506; 6,7-Dihydroxycoumarin, 98%; ZINC57908; EINECS 206-161-5; cid_5281416; BRD-K58149231-001-06-9; 2H-1-Benzopyran-2-one, 6,7-dihydroxy-; bmse000986; 4CN-0872; 6,7-dihydroxy-1-benzopyran-2-one; BN0888; HMS2097L22; Bio-0588; SPBio_003049; C9H6O4; E-3400; KBio2_004214; Spectrum_001166; Esculetin, analytical standard; 2H-1-Benzopyran-2-one, 6,7-dihydroxy- (9CI); N1764; 6,7-DIHYDROXYCOUMARIN; Coumarin, 6,7-dihydroxy- Esculetin; J10146; Esculetin, European Pharmacopoeia (EP) Reference Standard; ZB002263; Esculin aglucon; 6,7-dihydroxy-coumarin; KB-50565; NCI60_002119; ANW-43483; 6,7-Dihydroxy-2H-chromen-2-one; D0YZ5G; NCGC00016425-06; Jsp005751; AX8020100; AKOS000276955; NCGC00016425-02; CCRIS 7065; 6,7-Dihydroxy-2H-chromen-2-one #; Spectrum3_000752	C9H6O4	178.14 g/mol	C1=CC(=O)OC2=CC(=C(C=C21)O)O
TCMBANKIN058724	(+)-eudesma-4(15),7(11)-dien-8-one		C15H22O		CC(=C1CC2C(=C)CCCC2(CC1=O)C)C
TCMBANKIN059121	polyporenicacid c	8EC05EK77F; UNII-8EC05EK77F; 465-18-9; polyporenic acid c	C31H46O4	482.7 g/mol	CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)O)C(=O)O
TCMBANKIN059425	atractylodin		C13H10O	182.22	CC=CC#CC#CC=CC1=CC=CO1
TCMBANKIN059819	atractylenolide i		C15H18O2	230.3	CC1=C2CC3C(=C)CCCC3(C=C2OC1=O)C
TCMBANKIN059820	atractylenolide iii; codonolactone		C15H20O3	248.32	CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)O)C
TCMBANKIN060056	atractylone;atractylon		C15H20O	216.32	CC1=COC2=C1CC3C(=C)CCCC3(C2)C
TCMBANKIN060103	5beta-hydroxyecdysterone		C27H44O8	496.6 g/mol	CC12CCC3C(=CC(=O)C4(C3(CC(C(C4)O)O)C)O)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O
TCMBANKIN060104	paristerone		C27H44O7	480.6 g/mol	CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O
TCMBANKIN060693	Sitogluside		C35H60O6	576.85g/mol	CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE007557

ID:

TCMBANKHE007557

植物拉丁名:

Herha Ajugae Ciliatae

功能与主治:

药用植物名:

白毛夏枯草

药用部位:

whole herb

临床特征:

1. Antitussive and expectorant. 2. Its acid-alcoholic extract exerts an antiasthmatic effect on experimental animals with asthma.3. Its alcoholic extract inhibits the growth of Streptococcus and Straphylococcus aureus in vitro.

治疗类型:

清热解毒药

TCM_ID_id:

3926

SymMap_id:

17

TCMSP_id:

903